REAP Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61K | Buy |
137
+77
| +128% | +$34.3K | 0.01% | 243 |
|
|
2025
Q1 | $29.1K | Buy |
60
+28
| +88% | +$13.6K | 0.01% | 270 |
|
|
2024
Q4 | $12.9K | Buy |
32
+1
| +3% | +$403 | ﹤0.01% | 339 |
|
|
2024
Q3 | $14.4K | Hold |
31
| – | – | ﹤0.01% | 312 |
|
|
2024
Q2 | $14.5K | Sell |
31
-3
| -9% | -$1.41K | ﹤0.01% | 283 |
|
|
2024
Q1 | $14.2K | Buy |
+34
| New | +$14.2K | ﹤0.01% | 330 |
|